Pharma stocks face volatility on us plan to reduce drug prices

Companies in the news ...and how they were assessed

Drug bust-up: Novo Nordisk is to end its partnership with Hims & Hers Health after less than two months owing to the latter’s sale and promotion of cheap knock-offs of the weight-loss drug Wegovy, say

Issue of the week: are markets too complacent? ...

Oil shock averted? World leaders and commodity traders have spent the past fortnight on edge as the long-running Iran-Israel conflict turned hot. Matters came to a head at the weekend when the US dire

Why stocks armed with patents can outperform

Issue of the week: the US/UK trade accord ...